An antibody to a glial potassium channel was present in almost half of a cohort of patients with MS and resulted in inflammation when injected into mice.
Multiple sclerosis (MS) is thought to be an autoimmune disease, but the pathogenetic autoantibody has not been identified. In search of such an autoantibody, researchers isolated immunoglobulin G (IgG) antibodies from the serum of 12 individuals with MS. The antibodies were enriched for antigenicity against central nervous system membranes, separated by isoelectric focusing, and analyzed by gel electrophoresis and mass spectrometry.
One electrophoresis spot contained KIR4.1, a potassium channel on astroglia thought to affect myelin development and axonal signal transduction. Among 397 people with MS who were tested, 186 (46.9%) had antibodies to KIR4.1, compared with 3 of 329 (0.9%) with other neurological diseases and none of 59 healthy con…
Reviewing Author
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)